CC
BCAB

Centiva Capital’s BIOATLA INC BCAB Stock Holding History

Centiva Capital’s Portfolio BCAB Stock Details BCAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-1,808
Closed -$124K – 2141
2024
Q2 		$124K Buy
+1,808
New +$215K ﹤0.01% 1812

Other funds holding BCAB

Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $304B AUM 35.64% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Centiva Capital's BCAB Position: Q3 2024 in Review

Centiva Capital sold out of BIOATLA INC (BCAB) in Q3 2024, closing a stake of 1,808 shares — an estimated $124K sold.

Centiva Capital first reported a position in BCAB in Q2 2024 and held it in 1 quarter. The position peaked at $124K in Q2 2024. 63 funds tracked by Wall St. Rank hold BCAB as of Q3 2024.

  • Centiva Capital reported no remaining BIOATLA INC position as of Q3 2024 after selling out during the quarter.
  • Centiva Capital sold 1,808 BIOATLA INC shares in Q3 2024, an estimated $124K.
  • Centiva Capital first reported a position in BIOATLA INC in Q2 2024 and held it in 1 quarter.
  • Centiva Capital's BIOATLA INC position peaked at $124K in Q2 2024.
  • 63 funds tracked by Wall St. Rank held BIOATLA INC as of Q3 2024.

Based on Centiva Capital's 13F filing for Q3 2024, filed 14 Nov 2024.